Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma
Phase 2
Completed
- Conditions
- Lymphoma
- Interventions
- Biological: Autologous Tumor Cell-Based Vaccine
- First Posted Date
- 2005-01-10
- Last Posted Date
- 2023-08-22
- Target Recruit Count
- 43
- Registration Number
- NCT00101101
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma
Phase 2
Completed
- Conditions
- Melanoma (Skin)
- Interventions
- Biological: Bystander-Based Autologous Tumor Cell Vaccine
- First Posted Date
- 2005-01-10
- Last Posted Date
- 2018-02-28
- Target Recruit Count
- 43
- Registration Number
- NCT00101166
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer
- First Posted Date
- 2005-01-07
- Last Posted Date
- 2013-08-16
- Target Recruit Count
- 18
- Registration Number
- NCT00100906
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
- First Posted Date
- 2004-08-10
- Last Posted Date
- 2012-09-25
- Target Recruit Count
- 10
- Registration Number
- NCT00005626
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
Phase 2
Terminated
- Conditions
- Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
CI-994 in Treating Patients With Advanced Myeloma
- First Posted Date
- 2004-07-26
- Last Posted Date
- 2012-09-25
- Target Recruit Count
- 6
- Registration Number
- NCT00005624
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Management of Metastatic Breast Cancer in Frail Patients
BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment
Phase 1
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
- First Posted Date
- 2004-06-25
- Last Posted Date
- 2013-06-04
- Target Recruit Count
- 147
- Registration Number
- NCT00005613
- Locations
- 🇺🇸
Florida Cancer Specialists, Fort Myers, Florida, United States
🇺🇸H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
Phase 1
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath